版本:
中国

BRIEF-Biocept announces collaboration with the OHSU Knight Cancer Institute

April 3 Biocept Inc

* Biocept announces collaboration with the OHSU Knight Cancer Institute to increase clinical adoption of liquid biopsy testing and to co-develop additional assay platform capabilities

* Biocept Inc - financial terms were not disclosed

* Biocept Inc - agreement grants OHSU rights to commercially offer co's target selector liquid biopsy testing services exclusively throughout Oregon

* Biocept Inc - Biocept and OHSU also plan to co-develop additional liquid biopsy assay technologies and platform capabilities Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐